NCT04389632: A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- State
- Under way
- Phase
- Phase 1
- People
- 1,006 planned
- Started
- 8 Jun 2020
- Primary completion
- 16 Jun 2027
- Arms
- Part C: sigvotatug vedotin combination therapy in NSCLC, HNSCC, ESCC, Part D: sigvotatug vedotin combination therapy in 1L HNSCC
- Results
- None posted
- 15 May 2020: Trial registered
- 8 Jun 2020: Trial started